{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:30:04Z","timestamp":1772429404841,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["72X-8273"],"award-info":[{"award-number":["72X-8273"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.bbrc.2012.06.011","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T08:39:03Z","timestamp":1339317543000},"page":"583-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice"],"prefix":"10.1016","volume":"423","author":[{"given":"T","family":"Rydgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"B\u00f6rjesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.06.011_b0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0896-8411(95)90001-2","article-title":"Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation","volume":"8","author":"Bach","year":"1995","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbrc.2012.06.011_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/03009734000000053","article-title":"Novel experimental strategies to prevent the development of type 1 diabetes mellitus","volume":"105","author":"Sandler","year":"2000","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2012.06.011_b0015","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1016\/S0021-9258(18)67324-7","article-title":"Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing","volume":"261","author":"Mojsov","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.06.011_b0020","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1016\/S0021-9258(18)68261-4","article-title":"Glucagon gene expression in vertebrate brain","volume":"263","author":"Drucker","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.06.011_b0025","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/S0021-9258(19)39030-1","article-title":"Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas","volume":"265","author":"Mojsov","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 5","key":"10.1016\/j.bbrc.2012.06.011_b0030","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.ijo.0801912","article-title":"Glucagon-like peptide containing pathways in the regulation of feeding behavior","author":"Tang-Christensen","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.bbrc.2012.06.011_b0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/isl.2.3.11396","article-title":"Intraislet production of GLP-1 by activation of prohormone convertase 1\/3 in pancreatic \u03b1-cells in mouse models of \u03b2-cell regeneration","volume":"2","author":"Kilimnik","year":"2010","journal-title":"Islets"},{"key":"10.1016\/j.bbrc.2012.06.011_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0094","article-title":"Processing of proglucagon to GLP-1 in pancreatic \u03b1-cells: is this a paracrine mechanism enabling GLP-1 to act on \u03b2-cells?","volume":"211","author":"Whalley","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbrc.2012.06.011_b0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.physiol.59.1.257","article-title":"Enteroglucagon","volume":"59","author":"Holst","year":"1997","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbrc.2012.06.011_b0050","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2012.06.011_b0055","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"Deacon","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2012.06.011_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2005.05.001","article-title":"A human glucagon-like peptide-1 receptor polymorphism result in reduced agonist responsiveness","volume":"130","author":"Beinborn","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbrc.2012.06.011_b0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2009.11.007","article-title":"Insulin-like actions of glucagon-like peptide-1 a dual receptor hypothesis","volume":"21","author":"Tomas","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2012.06.011_b0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2012.06.011_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0026-0495(97)90251-1","article-title":"Incretin hormone expression in the gut of diabetic mice and rats","volume":"46","author":"Bergh\u00f6fer","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2012.06.011_b0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0065-2776(08)60490-3","article-title":"The murine autoimmune diabetes model: NOD and related strains","volume":"51","author":"Kikutani","year":"1992","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbrc.2012.06.011_b0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","article-title":"The NOD mouse model of type 1 diabetes: as good as it gets?","volume":"5","author":"Atkinson","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2012.06.011_b0090","unstructured":"A. Carlsson, M. Simonsson, R. Boman, M. Eberlein, P Lindstedt, Relevance of sample collection method and specificity for the quantification of GLP-1 in two new ELISA assays for active and total GLP-1, Diabetologia 53 (Suppl. 1) (2010) (A859 Abstract)."},{"key":"10.1016\/j.bbrc.2012.06.011_b0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: a model of immune dysregulation","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2012.06.011_b0100","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2012.06.011_b0105","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diabetes.50.7.1562","article-title":"Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age","volume":"50","author":"Tourrel","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2012.06.011_b0110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","article-title":"Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice","volume":"45","author":"Wang","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2012.06.011_b0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1074\/jbc.M209423200","article-title":"Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.06.011_b0120","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00125-007-0737-6","article-title":"Continuous stimulation of human glucagon-like peptide-1 (7\u201336) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes","volume":"50","author":"Zhang","year":"2007","journal-title":"Diabetologia"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12010844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12010844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:26:20Z","timestamp":1762093580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12010844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0006291X12010844"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.06.011","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}